Literature DB >> 6199209

Mitogenic and polyclonal B cell activation activities of synthetic lipid A analogues.

Y Kumazawa, M Matsuura, Y Nakatsuru-Watanabe, M Fukumoto, C Nishimura, J Y Homma, M Inage, S Kusumoto, T Shiba.   

Abstract

The activation of murine B cells and macrophages by synthetic lipid A analogues, solubilized with triethylamine and complexed with bovine serum albumin, were investigated in vitro. The analogues used are nonphosphorylated, C-1 or C-4' monophosphorylated and C-1,4' diphosphorylated derivatives of beta-1,6-linked D-glucosamine disaccharide possessing both ester- and amide-bound fatty acid substituents. They were divided into 4 groups, A, B, C and D in terms of the fatty acid substitution. Ester- and amine-bound fatty acids of the analogues are both tetradecanoic acids (C14) in group A, C14 and (R)-3-hydroxytetradecanoic acids (C14-OH) in group B, both C14-OH in group C and C14-OH and (R)-3-tetradecanoyloxytetradecanoic acids in group D. Mitogenic activity was exhibited in spleen cells from C3H/HeN mice by the C-1 monophosphorylated analogues in groups A and B, and by the C-4' monophosphorylated analogues in groups B, C and D, but not in cells from C3H/HeJ mice. Nonphosphorylated analogues in groups A, B and C, and C-4' monophosphorylated analogue in group A showed negative mitogenic activity. Only the nonphosphorylated analogue in group D exhibited mitogenic activity in spleen cells from C3H/HeJ mice as well as those from C3H/HeN mice. None of the other analogues exhibited the activity in C3H/HeJ spleen cells. Polyclonal B cell activation activity was exhibited by the C-1 monophosphorylated analogues in groups A and B, and by the C-4' monophosphorylated analogues in groups C and D. Nonphosphorylated analogues in all groups and C-4' monophosphorylated analogues in groups A and B showed negative PBA activity. None of the analogues tested could induce any cytostatic macrophages from thioglycollate-elicited peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199209     DOI: 10.1002/eji.1830140202

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Inhibition of activated nonresponder C3H/HeJ lymphocytes by lipopolysaccharide endotoxin.

Authors:  B M Sultzer; R Castagna
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.

Authors:  Y Kumazawa; M Matsuura; J Y Homma; T Furuya; H Takimoto; K Inagaki; T Nagumo; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A.

Authors:  K Tanamoto; C Galanos; O Lüderitz; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Immunopotentiator separated from hot water extract of the seed of Benincasa cerifera Savi (Tohgashi).

Authors:  Y Kumazawa; Y Nakatsuru; A Yamada; T Yadomae; C Nishimura; Y Otsuka; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Authors:  H Takada; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; K Harada; C Katsukawa; S Tanaka; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

6.  Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.

Authors:  Y Kumazawa; M Nakatsuka; H Takimoto; T Furuya; T Nagumo; A Yamamoto; Y Homma; K Inada; M Yoshida; M Kiso
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.